当前位置:首页 - 行情中心 - 翔宇医疗(688626) - 财务分析 - 现金流量表

翔宇医疗

(688626)

  

流通市值:88.32亿  总市值:88.32亿
流通股本:1.60亿   总股本:1.60亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金437,110,263.39217,513,974.91867,521,952.22576,098,588.92
  收到的税费返还7,897,672.486,298,746.5115,760,854.4112,537,252.71
  收到其他与经营活动有关的现金24,952,835.3714,911,313.0542,207,463.6148,620,404.81
  经营活动现金流入小计469,960,771.24238,724,034.47925,490,270.24637,256,246.44
  购买商品、接受劳务支付的现金142,961,167.1887,281,076.14244,882,106.53199,283,002.29
  支付给职工以及为职工支付的现金161,584,128.377,478,682267,520,661.1172,921,933.1
  支付的各项税费31,695,124.5517,272,543.2359,971,458.6349,280,312.18
  支付其他与经营活动有关的现金80,524,005.7135,847,516.83174,521,604.82122,792,293.5
  经营活动现金流出小计416,764,425.74217,879,818.2746,895,831.08544,277,541.07
  经营活动产生的现金流量净额53,196,345.520,844,216.27178,594,439.1692,978,705.37
二、投资活动产生的现金流量:
  收回投资收到的现金5,150,712---
  取得投资收益收到的现金931,405.6422,125.611,255,114.343,195,636.51
  处置固定资产、无形资产和其他长期资产收回的现金净额21,374.06137.9880,50013,000
  收到的其他与投资活动有关的现金--332,000,000321,054,190.59
  投资活动现金流入小计6,103,491.66422,263.59333,335,614.34324,262,827.1
  购建固定资产、无形资产和其他长期资产支付的现金192,917,997.2485,263,693.95438,890,635.9352,187,014.52
  投资支付的现金--200,000-
  支付其他与投资活动有关的现金100,000,000100,000,000170,000,000159,054,190.59
  投资活动现金流出小计292,917,997.24185,263,693.95609,090,635.9511,241,205.11
  投资活动产生的现金流量净额-286,814,505.58-184,841,430.36-275,755,021.56-186,978,378.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金17,849,160---
  取得借款收到的现金233,090,000181,090,000338,000,000324,000,000
  收到其他与筹资活动有关的现金411,000,000327,849,160178,000,000168,000,000
  筹资活动现金流入小计661,939,160508,939,160516,000,000492,000,000
  偿还债务支付的现金203,990,000106,990,000189,010,000182,025,000
  分配股利、利润或偿付利息支付的现金40,915,441.237,284,247.4785,865,792.2785,178,791.16
  其中:子公司支付给少数股东的股利、利润--275,000-
  支付其他与筹资活动有关的现金181,003,394.59201,896,833.4992,746,208.5473,562,492.18
  筹资活动现金流出小计425,908,835.82316,171,080.96367,622,000.81340,766,283.34
  筹资活动产生的现金流量净额236,030,324.18192,768,079.04148,377,999.19151,233,716.66
四、汇率变动对现金及现金等价物的影响-84,566.119,167.12-72,176.93125,089.16
五、现金及现金等价物净增加额2,327,59828,790,032.0751,145,239.8657,359,133.18
  加:期初现金及现金等价物余额702,912,552.43702,912,552.43651,767,312.57651,767,312.57
  期末现金及现金等价物余额705,240,150.43731,702,584.5702,912,552.43709,126,445.75
补充资料:
  净利润33,482,193.16-102,853,096.06-
  资产减值准备2,353,330.71-9,188,838.54-
  固定资产和投资性房地产折旧21,285,691.33-30,565,107.15-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧21,285,691.33-30,565,107.15-
  无形资产摊销3,961,444.95-7,255,483.58-
  长期待摊费用摊销2,029,115.05-2,248,199.31-
  处置固定资产、无形资产和其他长期资产的损失21,374.06--66,478.93-
  固定资产报废损失--49,296.68-
  财务费用3,846,168.64-3,555,583.6-
  投资损失-6,082,117.6--1,400,899.49-
  递延所得税2,048,179.59-1,665,336.41-
  其中:递延所得税资产减少2,048,179.59-1,665,336.41-
  存货的减少-26,806,380.69--6,004,621.48-
  经营性应收项目的减少-8,894,867.75--20,713,241.22-
  经营性应付项目的增加24,122,208.94-38,226,045.67-
  其他--5,101,686.26-
  现金的期末余额705,240,150.43-702,912,552.43-
  减:现金的期初余额702,912,552.43-651,767,312.57-
  现金及现金等价物的净增加额2,327,598-51,145,239.86-
公告日期2025-08-292025-04-252025-04-252024-10-30
审计意见(境内)标准无保留意见
TOP↑